|
1
|
Chen QY, Zheng Y, Jiao DM, Chen FY, Hu HZ,
Wu YQ, Song J, Yan J, Wu LJ and Lv GY: Curcumin inhibits lung
cancer cell migration and invasion through Rac1-dependent signaling
pathway. J Nutr Biochem. 25:177–185. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Feng B, Zhang K, Wang R and Chen L:
Non-small-cell lung cancer and miRNAs: Novel biomarkers and
promising tools for treatment. Clin Sci (Lond). 128:619–634. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Johnson DH: Locally advanced, unresectable
non-small cell lung cancer: New treatment strategies. Chest. 117
Suppl 1:S123–S126. 2000. View Article : Google Scholar
|
|
4
|
Deveraux QL and Reed JC: IAP family
proteins - suppressors of apoptosis. Genes Dev. 13:239–252. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Holcik M, Gibson H and Korneluk RG: XIAP:
Apoptotic brake and promising therapeutic target. Apoptosis.
6:253–261. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Chia CY, Kumari U and Casey PJ: Breast
cancer cell invasion mediated by Gα12 signaling involves expression
of interleukins-6 and −8, and matrix metalloproteinase-2. J Mol
Signal. 9:62014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Stoeltzing O, Ahmad SA, Liu W, McCarty MF,
Wey JS, Parikh AA, Fan F, Reinmuth N, Kawaguchi M, Bucana CD, et
al: Angiopoietin-1 inhibits vascular permeability, angiogenesis,
and growth of hepatic colon cancer tumors. Cancer Res.
63:3370–3377. 2003.PubMed/NCBI
|
|
8
|
Zhang W, Wang F, Xu P, Miao C, Zeng X, Cui
X, Lu C, Xie H, Yin H, Chen F, et al: Perfluorooctanoic acid
stimulates breast cancer cells invasion and up-regulates matrix
metalloproteinase-2/-9 expression mediated by activating NF-κB.
Toxicol Lett. 229:118–125. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Iochmann S, Bléchet C, Chabot V, Saulnier
A, Amini A, Gaud G, Gruel Y and Reverdiau P: Transient RNA
silencing of tissue factor pathway inhibitor-2 modulates lung
cancer cell invasion. Clin Exp Metastasis. 26:457–467. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Safranek J, Pesta M, Holubec L, Kulda V,
Dreslerova J, Vrzalova J, Topolcan O, Pesek M, Finek J and Treska
V: Expression of MMP-7, MMP-9, TIMP-1 and TIMP-2 mRNA in lung
tissue of patients with non-small cell lung cancer (NSCLC) and
benign pulmonary disease. Anticancer Res. 29:2513–2517.
2009.PubMed/NCBI
|
|
11
|
Shi Y and Sun Y: Medical management of
lung cancer: Experience in China. Thorac Cancer. 6:10–16. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Gridelli C, Aapro M, Ardizzoni A, Balducci
L, De Marinis F, Kelly K, Le Chevalier T, Manegold C, Perrone F,
Rosell R, et al: Treatment of advanced non-small-cell lung cancer
in the elderly: Results of an international expert panel. J Clin
Oncol. 23:3125–3137. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Hu W, Wang F, Tang J, Liu X, Yuan Z, Nie C
and Wei Y: Proapoptotic protein Smac mediates apoptosis in
cisplatin-resistant ovarian cancer cells when treated with the
anti-tumor agent AT101. J Biol Chem. 287:68–80. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Hussain AR, Uddin S, Ahmed M, Bu R, Ahmed
SO, Abubaker J, Sultana M, Ajarim D, Al-Dayel F, Bavi PP, et al:
Prognostic significance of XIAP expression in DLBCL and effect of
its inhibition on AKT signalling. J Pathol. 222:180–190. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Shangary S and Wang S: Targeting the
MDM2-p53 interaction for cancer therapy. Clin Cancer Res.
14:5318–5324. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Shangary S, Qin D, McEachern D, Liu M,
Miller RS, Qiu S, Nikolovska-Coleska Z, Ding K, Wang G, Chen J, et
al: Temporal activation of p53 by a specific MDM2 inhibitor is
selectively toxic to tumors and leads to complete tumor growth
inhibition. Proc Natl Acad Sci USA. 105:3933–3938. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Scoumanne A and Chen X: Protein
methylation: A new mechanism of p53 tumor suppressor regulation.
Histol Histopathol. 23:1143–1149. 2008.PubMed/NCBI
|
|
18
|
Lu C and El-Deiry WS: Targeting p53 for
enhanced radio- and chemo-sensitivity. Apoptosis. 14:597–606. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Fernandez-Garcia B, Eiró N, Marín L,
González-Reyes S, González LO, Lamelas ML and Vizoso FJ: Expression
and prognostic significance of fibronectin and matrix
metalloproteases in breast cancer metastasis. Histopathology.
64:512–522. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Parsons SL, Watson SA, Collins HM, Griffin
NR, Clarke PA and Steele RJ: Gelatinase (MMP-2 and −9) expression
in gastrointestinal malignancy. Br J Cancer. 78:1495–1502. 1998.
View Article : Google Scholar : PubMed/NCBI
|
